Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 230-234 , 15 August 2009

Therapeutic potential of statins in Alzheimer's disease

  • Nagaendran Kandiah
    • ,
  • Howard H. Feldman

      Affiliations

    • Corresponding Author InformationCorresponding author. Division of Neurology, University of British Columbia Hospital, S192-2211 Westbrook Mall, Vancouver, British Columbia, Canada V6T 2B5. Tel.: +1 604 822 7979; fax: +1 604 822 7703.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Disclosures: Dr. Howard Feldman has received grant research support from Pfizer, Eisai, Janssen, Lilly, Astra Zeneca, Sanofi Synthelabo and Glaxo Smith Kline. He has served as consultant for Pfizer, Novartis, Janssen, Servier, Sanofi Synthelabo, Glaxo Smith Kline, Myriad, Targacept, Lundbeck, Forest and Avonyx. Dr. Nagaendran Kandiah has no conflicts of interest to disclose.

PII: S0022-510X(09)00441-9

doi: 10.1016/j.jns.2009.02.352

Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 230-234 , 15 August 2009

Article Tools

* Image Usage & Resolution